https://www.selleckchem.com/pr....oducts/talabostat.ht
Treatment strategies for cutaneous squamous cell carcinoma in situ (cSCCIS) are many but reported cure rates are variable and few studies report 5-year follow-up data. To evaluate the treatment of cSCCIS by curettage followed by topical imiquimod 5% cream (CI). We evaluated all immunocompetent patients with biopsy proven cSCCIS treated by CI between January 2008 and December 2012. A total of 861 patients with 1,198 cSCCIS were treated, with median follow-up of 71 months. The mean tumor diameter was 10.2 mm. The average dura
Like
Comment
Share
